BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Holanda MI, Gomes CP, Araujo SA, Wanderley DC, Eick RG, Dantas GC, Tino MKDS, Pesquero JB, Palma LMP. Diacylglycerol kinase epsilon nephropathy: late diagnosis and therapeutic implications. Clin Kidney J 2019;12:641-4. [PMID: 31583090 DOI: 10.1093/ckj/sfz043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Alabdulqader M, Alfakeeh K. A patient with a homozygous diacylglycerol kinase epsilon (DGKE) gene mutation with atypical haemolytic uraemic syndrome and low C3 responded well to eculizumab: a case report. BMC Nephrol 2021;22:140. [PMID: 33879077 DOI: 10.1186/s12882-021-02352-8] [Reference Citation Analysis]
2 Palma LMP. Rare and Complex: lessons from a cohort of patients with Atypical Hemolytic Uremic Syndrome. J Bras Nefrol 2021;43:295-6. [PMID: 34057986 DOI: 10.1590/2175-8239-JBN-2021-0066] [Reference Citation Analysis]
3 Palma LMP, Eick RG, Dantas GC, Tino MKDS, de Holanda MI; Brazilian Thrombotic Microangiopathy and Atypical Hemolytic Uremic Syndrome Study Group (aHUS Brazil). Atypical hemolytic uremic syndrome in Brazil: clinical presentation, genetic findings and outcomes of a case series in adults and children treated with eculizumab. Clin Kidney J 2021;14:1126-35. [PMID: 33841858 DOI: 10.1093/ckj/sfaa062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Fu W, Li M, Lin H, Xu Y, Han W, Chen H, Sun L. Cyclosporine A relieved proteinuria and hypoproteinemia in DGKE nephropathy. Clin Chim Acta 2021;518:78-82. [PMID: 33741360 DOI: 10.1016/j.cca.2021.02.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Palma LMP, Vaisbich-Guimarães MH, Sridharan M, Tran CL, Sethi S. Thrombotic microangiopathy in children. Pediatr Nephrol 2022. [PMID: 35041041 DOI: 10.1007/s00467-021-05370-8] [Reference Citation Analysis]